Programmed cell death in the developing heart.
van den Hoff
M J
MJ
Cardiovascular Research Institute Amsterdam, Academic Medical Center, The Netherlands. m.j.vandenhoff@amc.uva.nl
van den Eijnde
S M
SM
Virágh
S
S
Moorman
A F
AF
D000818:Animals; D030801:Animals, Genetically Modified; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D020169:Caspases / Q000378:metabolism; D002462:Cell Membrane / Q000378:metabolism; D002645:Chickens; D053938:DNA Fragmentation; D005865:Gestational Age; D006321:Heart / Q000196:embryology* / Q000502:physiology*; D006801:Humans; D020935:MAP Kinase Signaling System; D008929:Mitochondria, Heart / Q000378:metabolism; D010718:Phosphatidylserines / Q000378:metabolism; D051381:Rats; D018124:Receptors, Tumor Necrosis Factor / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*; D013045:Species Specificity; D013723:Teratogens / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D010718:Phosphatidylserines; D018124:Receptors, Tumor Necrosis Factor; D013723:Teratogens; D014409:Tumor Necrosis Factor-alpha; D020169:Caspases